Font Size:
Site Colors:
Accesskey
S - Skip navigation
1 - Home page
4 - Search
Accessibility Statement

Clinical Solution

Personalized treatment

The brain-stimulation medical device developed by Innosphere provides personalized treatment for ADHD, by applying accurate electric stimulation signals to specific areas of the brain associated with the disorder.

Customized machine-learning based treatment sessions are uploaded to a head-cap from a proprietary digital health platform, and applied for up to 20 minutes, 3 times a week over the course of a month.

This state-of-the-art AF-RNS™ technology transforms the lives of millions of children and their parents.

 

img_20181112113141.543.png

Clinical trials

Several clinical studies conducted at top medical centers by key opinion leaders in the field of ADHD, have already yielded significant results showing major improvement in multiple measures of ADHD. These preliminary clinical results have demonstrated that the INNOSPHERE technology provides a viable, long-term therapeutic solution for the disorder.

Hadassah Medical Center

A clinical trial run at Hadassah medical center on 100 boys ages 7-12, led by Dr. Itai Berger, Head of Pediatric Neurology Unit at Assuta Hospital, yielded positive preliminary results, showing significant improvement in the frequency of ADHD symptoms. There was substantial improvement in working memory, and overall symptom alleviation. The effects remained at similar levels when re-examined one week later.

Based on the improvement in working memory, this type of treatment could be potentially used for treating additional disorders that are associated with impaired executive functions, such as cognitive impairments.

Prilimanry results in this trial, on 20 participants, have shown significant reduction of over 50% of ADHD symptom severity after only 5 treatment session

King’s College of London

A study on 50 boys ages 8-18, led by Prof. Katya Rubia, Professor of Cognitive Neuroscience and key opinion leader in ADHD (expected results: end of 2019).

Upcoming trials:

  • Charité Medical Center in collaboration with the University of Oxford (Berlin, Germany)
  • Assuta Medical Center (large HMO in Israel)
  • Tubingen University (Germany)
Name
Price
Quanity
Del.
Confirm and pay
x We use cookies to enhance the experience on our website. More about cookies.
✓ Accept